Foundation for USP7 Related Diseases Makes Grant to Neurolentech
Share
Rare Daily Staff
The Foundation for USP7 Related Diseases said it awarded a two-year $100,000 grant to Neurolentech in a search for a cure for the rare disease Hao-Fountain syndrome, which is caused by USP7 mutations.
The Austrian startup Neurolentech, co-founded by Gaia Novarino, a professor of neuroscience at the Institute of Science and Technology Austria (IST Austria), will receive $100,000 over two years towards funding studies that will focus on modeling Hao-Fountain syndrome in cells.
Hao-Fountain syndrome is a rare genetic disorder caused by mutations in the USP7 gene, with just 80 known patients worldwide. It leads to autism spectrum disorder, increased prevalence of epilepsy, developmental delay/intellectual disability, abnormal brain MRIs, speech impairment, hypotonia, gastrointestinal issues, and eye anomalies.
Austria
France
Austrian
Gaia-novarino
Technology-austria
Institute-of-science
Manger-la-vie
ஆஸ்ட்ரியா
பிரான்ஸ்
ஆஸ்திரேலிய
தொழில்நுட்பம்-ஆஸ்ட்ரியா
நிறுவனம்-ஆஃப்-அறிவியல்